Inozyme Pharma, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Inozyme Pharma, Inc.
CIK #0001693011
EDGAR Form CIK 2011 - 2025
10-K [0001693011]
10-Q [0001693011]
3 [0001693011]
4 [0001693011]
8-K [0001693011]
D [0001693011]
SC 13D [0001693011]
SC 13G [0001693011]
Form 13D/13G Filer Form 13D/13G Subject Filed
Glazer Capital LLC Inozyme Pharma Inc [2025-06-04]
Beryl Capital Management LLC Inozyme Pharma Inc [2025-05-23]
Affinity Asset Advisors LLC Inozyme Pharma Inc [2024-12-09]
BlackRock Inc Inozyme Pharma Inc [2024-11-08]
BlackRock Inc Inozyme Pharma Inc [2024-10-24]
Eventide Asset Management LLC Inozyme Pharma Inc [2024-02-14]
Samlyn Capital LLC Inozyme Pharma Inc [2024-02-14]
Millennium Management LLC Inozyme Pharma Inc [2023-05-31]
Sphera Funds Management Ltd Inozyme Pharma Inc [2023-03-07]
Baker Bros Advisors LP Inozyme Pharma Inc [2023-02-14]
View All
Form 3/4/5 Subject 2011 - 2025
Inozyme Pharma, Inc.
Subramanian Sanjay
Hopfner Robert Lorne
Treco Douglas A
Sullivan Lynne Marie
Bolte Axel
Winton Matthew
Harris Erik
Diaz Reinaldo M
Edwards Martin
View All
Terms | Privacy | Guide
tony@aum13f.com